Global Glycated Albumin Market Growth 2025-2031

The global Glycated Albumin market size is predicted to grow from US$ 461 million in 2025 to US$ 621 million in 2031; it is expected to grow at a CAGR of 5.1% from 2025 to 2031.

Diabetes afflicts an increasing number of people worldwide each year. Proper blood glucose control is essential in preventing complications associated with diabetes, such as neuropathy, nephropathy and retinopathy.



Glycation is the result of a sugar molecule, such as fructose or glucose, bonding to a protein or lipid molecule without the controlling action of an enzyme. It is a haphazard process that impairs the functioning of biomolecules. The high levels of glucose present in diabetes meatus results in increased glycation of all proteins, including, albumin. Measurement of the amount of the glycation reaction resulting from the combination of glucose with free amino groups in proteins present in the blood is used to monitor the level of glucose that has generally been present in body fluids over a preceding period.



Thus serum glycated albumin assay can be used to determine the current level of glycation of albumin, the most abundant plasma protein. Hence, the gycated albumin assay may be used as a marker of glycemic control in diabetes and reflects glycemic control over the precious 2 to 4 weeks.

The major players in global Glycated Albumin market include Asahi Kasei Pharma, DIAZYME, Abnova, etc. The top 3 players occupy about 85% shares of the global market. Asia-Pacific and Europe are main markets, they occupy about 60% of the global market. Glycated Albumin (Animal) is the main type, with a share about 60%. Hospitals and Clinics is the main application, which holds a share about 50%.

LP Information, Inc. (LPI) ' newest research report, the “Glycated Albumin Industry Forecast” looks at past sales and reviews total world Glycated Albumin sales in 2024, providing a comprehensive analysis by region and market sector of projected Glycated Albumin sales for 2025 through 2031. With Glycated Albumin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Glycated Albumin industry.

This Insight Report provides a comprehensive analysis of the global Glycated Albumin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Glycated Albumin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Glycated Albumin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Glycated Albumin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Glycated Albumin.

This report presents a comprehensive overview, market shares, and growth opportunities of Glycated Albumin market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Glycated Albumin (Human)
Glycated Albumin (Animal)

Segmentation by Application:
Hospitals and Clinics
Laboratories

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Asahi Kasei Pharma
DIAZYME
Abnova
LifeSpan
Exocell
BSBE
Medicalsystem
Maccura
Leadman
Simes Sikma
NINGBO PUREBIO

Key Questions Addressed in this Report

What is the 10-year outlook for the global Glycated Albumin market?

What factors are driving Glycated Albumin market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Glycated Albumin market opportunities vary by end market size?

How does Glycated Albumin break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.